PTX strategic collaboration with MD Anderson Cancer Center
Filed with ASX · · 4 pages · English
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- Prescient Therapeutics Launches Share Purchase Plan
- Appendix 4E and 2022 Annual Report
- PTX agreement with Thermo Fisher for scalable OmniCAR
- PTX OmniCAR cell manufacturing contract for clinical trials
- June 2022 Quarterly Update and Appendix 4C
Later from Prescient Therapeutics
- PTX unveils CellPryme-A to boost CAR-T performance
- SPP Results and Placement
- Placement Results
- PTX-100 Trial Update
- September 2022 Quarterly Update and Appendix 4C
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics